Physician
Sovereign Medical Group LLC
Sovereign Medical Group LLC was paid $8.29M by Medicaid between Jan 2018 and Nov 2024, across 131 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoSOVEREIGN MEDICAL GROUP LLC
ORADELL, NJ 07649
ORADELL, NJ 07649
33aNPI1710282082assigned 01/18/2011
33bProvider typeInternal Medicine Physician
28Total paid$8.29M
24GClaims182,651
24DCodes billed131
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in New Jersey
Rank by total paid#12 of 1,027
Median peer was paid$30K
This provider vs. median279×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,586 | $1.53M | |
| 2019 | 22,761 | $1.18M | |
| 2020 | 14,730 | $664K | |
| 2021 | 20,612 | $1.03M | |
| 2022 | 31,649 | $1.34M | |
| 2023 | 36,692 | $1.53M | |
| 2024incomplete | 26,621 | $1.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 45,923 | 40,870 | $2.26M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 20,808 | 18,977 | $1.60M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.0% | 9,114 | 8,824 | $748K |
| L3000 | Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each | 8.0% | 3,331 | 1,431 | $661K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 7.7% | 5,581 | 5,351 | $637K |
| 76872 | 3.6% | 4,093 | 3,782 | $295K | |
| 52224 | 3.3% | 1,091 | 990 | $272K | |
| 95913 | 2.7% | 1,152 | 1,003 | $222K | |
| 95886 | 2.3% | 1,427 | 1,247 | $189K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.8% | 4,084 | 3,834 | $150K |
| 76770 | 1.5% | 2,124 | 1,965 | $127K | |
| 73620 | 1.2% | 4,291 | 2,436 | $96K |
119 more codes
| 99401 | <1% | 3,469 | $68K | |
| 99442 | <1% | 1,278 | $61K | |
| 99223 | Prolong inpt eval add15 m | <1% | 721 | $58K |
| 95813 | <1% | 175 | $56K | |
| 52000 | <1% | 478 | $48K | |
| 11720 | <1% | 3,592 | $48K | |
| 51798 | <1% | 8,778 | $48K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,177 | $43K |
| 11721 | <1% | 1,870 | $40K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 205 | $35K |
| 11056 | <1% | 1,800 | $34K | |
| 95716 | <1% | 14 | $31K | |
| 11102 | <1% | 332 | $30K | |
| 99205 | Prolong outpt/office vis | <1% | 213 | $30K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 822 | $28K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 348 | $26K |
| 11100 | <1% | 217 | $22K | |
| 51741 | <1% | 1,076 | $21K | |
| 95117 | <1% | 1,654 | $21K | |
| 11104 | <1% | 173 | $21K | |
| 11900 | <1% | 402 | $20K | |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 55 | $20K |
| 76775 | <1% | 783 | $18K | |
| 73630 | <1% | 464 | $11K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,164 | $10K |
| 90746 | <1% | 189 | $10K | |
| 81002 | <1% | 18,434 | $9K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 909 | $9K |
| 20611 | <1% | 135 | $9K | |
| 95912 | <1% | 42 | $8K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,214 | $8K |
| G0127 | Trimming of dystrophic nails, any number | <1% | 1,624 | $7K |
| A5500 | For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe | <1% | 363 | $7K |
| 76857 | <1% | 546 | $6K | |
| A5512 | For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each | <1% | 269 | $6K |
| 95720 | <1% | 14 | $5K | |
| 95700 | <1% | 27 | $5K | |
| 73562 | <1% | 158 | $5K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 27 | $5K |
| 11103 | <1% | 61 | $5K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 37 | $4K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 26 | $4K |
| 17110 | <1% | 34 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 17 | $3K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 138 | $3K |
| 95812 | <1% | 12 | $3K | |
| S0395 | Impression casting of a foot performed by a practitioner other than the manufacturer of the orthotic | <1% | 105 | $3K |
| 87653 | <1% | 205 | $3K | |
| 87481 | <1% | 204 | $3K | |
| 11101 | <1% | 49 | $3K | |
| 99354 | <1% | 32 | $3K | |
| 93890 | <1% | 17 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,010 | $3K |
| 93886 | <1% | 15 | $3K | |
| 88121 | <1% | 220 | $2K | |
| 90686 | <1% | 154 | $2K | |
| 81001 | <1% | 1,125 | $2K | |
| 90658 | <1% | 103 | $2K | |
| 11719 | <1% | 497 | $2K | |
| 93892 | <1% | 17 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,053 | $2K |
| 81003 | <1% | 3,992 | $2K | |
| 92557 | <1% | 71 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 20 | $2K |
| 88341 | <1% | 42 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 167 | $1K |
| 99385 | <1% | 13 | $1K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 16 | $1K |
| 99443 | <1% | 31 | $1K | |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | <1% | 12 | $980.01 |
| 88360 | <1% | 208 | $967.61 | |
| 88342 | <1% | 400 | $919.41 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 55 | $827.22 |
| 11055 | <1% | 28 | $798.78 | |
| 20610 | <1% | 18 | $729.80 | |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 441 | $663.49 |
| 76942 | <1% | 15 | $644.35 | |
| 69210 | <1% | 25 | $599.70 | |
| 29540 | <1% | 27 | $560.53 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 46 | $502.85 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 15 | $450.32 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 15 | $448.68 |
| 87535 | <1% | 15 | $448.68 | |
| 87538 | <1% | 15 | $448.68 | |
| 87529 | <1% | 15 | $448.68 | |
| 87516 | <1% | 15 | $448.68 | |
| 87521 | Neg quan hep c or qual rna | <1% | 15 | $448.68 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 15 | $424.56 |
| 87563 | <1% | 15 | $416.90 | |
| 90688 | <1% | 36 | $385.23 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 15 | $351.13 |
| 97750 | <1% | 74 | $324.91 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 12 | $271.39 |
| 73610 | <1% | 13 | $265.96 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 35 | $262.24 |
| 92567 | <1% | 28 | $261.15 | |
| 88112 | <1% | 210 | $257.91 | |
| 92541 | <1% | 31 | $235.35 | |
| 93000 | <1% | 13 | $206.94 | |
| 98966 | <1% | 18 | $187.45 | |
| 87500 | <1% | 12 | $185.11 | |
| 86780 | <1% | 15 | $171.37 | |
| 51702 | <1% | 17 | $49.13 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 51 | $44.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 4,642 | $4.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 125 | $0.27 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,143 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,331 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 416 | $0.00 |
| 1160F | 0% | 155 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 133 | $0.00 |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 132 | $0.00 |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 36 | $0.00 |
| 3725F | 0% | 19 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 1,463 | $0.00 |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 64 | $0.00 |
| 1036F | 0% | 101 | $0.00 | |
| 3008F | 0% | 174 | $0.00 | |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAJJAR, JOHN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Children's Ambulatory Surgery Center of New Jersey, LLC | Fair Lawn, NJ | $12.40M |
| Sovereign Laboratory Services, LLC | Oradell, NJ | $1.51M |
| Surgicare Surgical Associates of Fairlawn, LLC | Fair Lawn, NJ | $546K |
| Surgicare Surgical Associates of Oradell, LLC | Oradell, NJ | $257K |
| Surgicare Surgical Associates of Wayne, LLC | Wayne, NJ | $217K |
| Surgicare Surgical Associates of Englewood Cliffs LLC | Englewood Cliffs, NJ | $82K |
| Wayne Cancer Center, LLC | Wayne, NJ | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.